Literature DB >> 2167139

Influence of chemotherapeutic agents on superoxide anion production by human polymorphonuclear leukocytes.

N Hara1, Y Ichinose, A Motohiro, T Kuda, H Aso, M Ohta.   

Abstract

The effects of 11 chemotherapeutic agents on superoxide anion (O2-) production were examined in human polymorphonuclear leukocytes (PMNL). All drugs, except predonine, were found to suppress O2- production in PMNL. Adriamycin (doxorubicin), mitomycin C, vindesine, cisplatin, etoposide, nimustine, and pepleomycin suppressed O2- production at relatively low drug concentrations, whereas methotrexate, 5-fluorouracil and vincristine suppressed O2- production at high drug concentrations. Time-dependent suppression of O2- production was evaluated in four drugs, namely Adriamycin (doxorubicin; Adria Laboratories, Columbus, OH), cisplatin, vindesine, and methotrexate. Only Adriamycin showed suppressive effect on PMNL-derived O2- production in a time-dependent manner. Production of O2- by PMNL is a fundamental element for its bactericidal activity. The authors' results showed suppression of O2- production in PMNL in the presence of chemotherapeutic agents. This indicates a relationship between chemotherapy drugs and susceptibility to infection. The influence of chemotherapeutic agents on O2- production by PMNL should thus be taken into consideration when assessing defense mechanisms and susceptibility to infection of patients treated with these drugs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167139     DOI: 10.1002/1097-0142(19900815)66:4<684::aid-cncr2820660416>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Interleukin-18 as a target for modulation of irinotecan-induced intestinal toxicity: a step towards a better therapeutic index?: Commentary on Lima-Junior et al., Br J Pharmacol 171: 2335-2350.

Authors:  B G Spyropoulos
Journal:  Br J Pharmacol       Date:  2015-10       Impact factor: 8.739

2.  Transient neutropenia after intravenous injection of vindesine in patients with lung cancer.

Authors:  K Aoshiba; A Nagai; H Ueno; K Konno
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  Factors related to impaired bactericidal activity in patients with esophageal cancer.

Authors:  Y Shigemitsu; T Saito; T Kinoshita; T Katsuta; K Shimoda; M Kobayashi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.